Bymetric
UK company intelligence
Company Active PRIVATE-LIMITED-GUARANT-NSC-LIMITED-EXEMPTION

Company profile

Versus Arthritis

UK company 00490500, incorporated on 13 January 1951.

Versus Arthritis | A future free from arthritis

We're Versus Arthritis. We wont rest until everyone with arthritis has access to the treatments and support they need to live the life they choose with real hope of a cure in the future.

Company number
00490500
Incorporated
13 Jan 1951
Companies House status
Active

Company identity

Founded / incorporated
13 January 1951

Company number 00490500

Verify at Companies House
Legal name
ARTHRITIS UK
Company type
PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Region
London
Registered address
3RD FLOOR
120 ALDERSGATE STREET
LONDON
ENGLAND
EC1A 4JQ
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

Controls 5
Versus Arthritis
No active corporate controller recorded.

Company events

Reference milestones and recent Companies House filing stream events.

5 events
04 Jun
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

21 May
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

13 Jan
1951

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2021
Funded years
2021
Age at first award
70 years

Projects

2021 Collaborative R&D

Transforming older adult disability through virtual, peer-led community rehabilitation: led by MSK charities

1 Jul 2021 to 30 Jun 2022

Awarded
£14,602
Total cost £14,602

Good Boost Wellbeing Limited (Good Boost) is a rapidly growing UK SME delivering cutting-edge medical technology. Combined with the collaboration, expertise and network access of the four largest musculoskeletal charities\* and Oxford Brookes University, Good Boost's unique AI-powered technology has the potential to save the NHS £16.4m by 2025\. Through t...

Product types

Collaborative R&D